Ye Lin, Yu Congcong, Xia Jiechao, Ni Kainan, Zhang Yejin, Ying Xiaozhang, Xie Dingqi, Jin Yang, Sun Rongtai, Tang Ruikang, Fan Shunwu, Yao Shasha
Department of Orthopaedic Surgery, Key Laboratory of Musculoskeletal System Degeneration and Regeneration Translational Research of Zhejiang Province, Sir Run Run Shaw Hospital, Medical College of Zhejiang University, Hangzhou, 310016, China.
Key Laboratory of Musculoskeletal System Degeneration and Regeneration, Translational Research of Zhejiang Province Hangzhou, Zhejiang, 310016, China.
Mater Today Bio. 2024 Feb 15;25:100996. doi: 10.1016/j.mtbio.2024.100996. eCollection 2024 Apr.
Reactive Oxygen Species (ROS) refers to a highly reactive class of oxidizing species that have the potential to induce cellular apoptosis and necrosis. Cuproptosis, a type of cell death, is primarily associated with the effects of copper ions. However, the specific relationship between ROS, cuproptosis, and osteosarcoma (OS) remains relatively unexplored. Additionally, there is limited research on the use of cuproptosis in conjunction with oxidative stress for treating OS and inhibiting tumor-induced bone destruction. To address these gaps, a novel treatment approach has been developed for OS and neoplastic bone destruction. This approach involves the utilization of glutathione (GSH) and pH-responsive organic-inorganic mesoporous silica nanoparticles@CuS@oxidized Dextran (short for MCD). The MCD material demonstrates excellent cytocompatibility, osteogenesis, tumor suppression, and the ability to inhibit osteoclast formation. The specific mechanism of action involves the mitochondria of the MCD material inhibiting key proteins in the tricarboxylic acid (TCA) cycle. Simultaneously, the generation of ROS promotes this inhibition and leads to alterations in cellular energy metabolism. Moreover, the MCD biomaterial exhibits promising mild-temperature photothermal therapy in the second near-infrared (NIR-II) range, effectively mitigating tumor growth and OS-induced bone destruction .
活性氧(ROS)是一类具有高反应活性的氧化物质,有可能诱导细胞凋亡和坏死。铜死亡作为一种细胞死亡类型,主要与铜离子的作用相关。然而,ROS、铜死亡与骨肉瘤(OS)之间的具体关系仍相对未被探索。此外,关于联合使用铜死亡与氧化应激来治疗骨肉瘤和抑制肿瘤诱导的骨破坏的研究也很有限。为了填补这些空白,已开发出一种针对骨肉瘤和肿瘤性骨破坏的新型治疗方法。该方法涉及利用谷胱甘肽(GSH)和pH响应性有机-无机介孔二氧化硅纳米颗粒@CuS@氧化葡聚糖(简称MCD)。MCD材料表现出优异的细胞相容性、成骨能力、肿瘤抑制能力以及抑制破骨细胞形成的能力。具体作用机制包括MCD材料的线粒体抑制三羧酸(TCA)循环中的关键蛋白。同时,ROS的产生促进这种抑制作用并导致细胞能量代谢的改变。此外,MCD生物材料在第二近红外(NIR-II)范围内展现出有前景的温和温度光热疗法,有效减轻肿瘤生长和骨肉瘤诱导的骨破坏。